Pharmanutra Balance Sheet Health
Financial Health criteria checks 5/6
Pharmanutra has a total shareholder equity of €48.7M and total debt of €25.7M, which brings its debt-to-equity ratio to 52.8%. Its total assets and total liabilities are €105.2M and €56.5M respectively. Pharmanutra's EBIT is €24.3M making its interest coverage ratio -357.3. It has cash and short-term investments of €10.3M.
Key information
52.8%
Debt to equity ratio
€25.71m
Debt
| Interest coverage ratio | -357.3x |
| Cash | €10.31m |
| Equity | €48.71m |
| Total liabilities | €56.49m |
| Total assets | €105.21m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PHNM's short term assets (€54.3M) exceed its short term liabilities (€25.5M).
Long Term Liabilities: PHNM's short term assets (€54.3M) exceed its long term liabilities (€31.0M).
Debt to Equity History and Analysis
Debt Level: PHNM's net debt to equity ratio (31.6%) is considered satisfactory.
Reducing Debt: PHNM's debt to equity ratio has increased from 24.9% to 52.8% over the past 5 years.
Debt Coverage: PHNM's debt is well covered by operating cash flow (34.7%).
Interest Coverage: PHNM earns more interest than it pays, so coverage of interest payments is not a concern.